Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells

per Steen, Nele Van Der, Potze, Lisette, Giovannetti, Elisa, Cavazzoni, Andrea, Ruijtenbeek, Rob, Rolfo, Christian, Pauwels, Patrick, Peters, Godefridus J
Publicat a Am J Cancer Res (2017)